Generated by All in One SEO Pro v4.9.10, this is an llms.txt file, used by LLMs to index the site.

# Alliance Clinical Network

Clinical Research Sites, Accelerated Trials, Diverse Populations

## Sitemaps

- [XML Sitemap](https://allianceclinicalnetwork.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [Eliminating Recruitment Barriers in Cardiometabolic Clinical Research](https://allianceclinicalnetwork.com/eliminating-recruitment-barriers-in-cardiometabolic-clinical-research/) - Diabetes, obesity, heart failure, chronic kidney disease, and atherosclerosis often overlap, creating layered eligibility barriers that complicate patient enrollment in cardiometabolic trials. At the same time, breakthrough therapies such as GLP-1 receptor agonists and evolving standards of care are reshaping who qualifies for participation. The result is that too many trials recruit slowly, overspend, and fail
- [Obesity trial surge puts the focus back on decentralisation](https://allianceclinicalnetwork.com/obesity-trial-surge-puts-the-focus-back-on-decentralisation/)
- [CNS Summit Poster Presentation: Enhancing Access and Diversity with Purpose-Built Study Sites](https://allianceclinicalnetwork.com/cns-summit-poster-presentation-enhancing-access-and-diversity-with-purpose-built-study-sites/) - Background The U.S. Food and Drug Administration (FDA) is actively seeking diversity in clinical trials. While Caucasians represent 58% of the U.S. population, they historically comprise 80% of participants across clinical trials.1 Only 6% of clinical trial participants are Hispanic, though this demographic accounts for 19% of the population.1 Despite increased regulatory emphasis on
- [Tackling High Screen Failure Rates and Boosting Diversity in CNS Clinical Trials](https://allianceclinicalnetwork.com/tackling-high-screen-failure-rates-and-boosting-diversity-in-cns-clinical-trials/) - High screen failure rates in central nervous system (CNS), neurological, and psychiatric clinical trials are among the most significant barriers to efficient trial execution. For clinical sponsors and contract research organizations (CROs), these failures drive up costs, prolong timelines, and complicate recruitment strategies. Compounding this challenge is the lack of participant diversity, which limits the
- [Overcoming Recruitment Challenges in the Current Vaccine Boom](https://allianceclinicalnetwork.com/overcoming-recruitment-challenges-in-the-current-vaccine-boom/) - As the vaccine industry advances, recruiting participants for clinical trials becomes more complex. Clinical development professionals face challenges such as compressed timelines, public trust deficits, and accessibility barriers, all while ensuring diversity and representation. Balancing technological innovation with inclusivity is essential to overcoming these obstacles and ensuring vaccines are developed safely, effectively, and equitably. This
- [A Practical Approach to Building Diversity into Clinical Trials Using Purpose-Built Sites](https://allianceclinicalnetwork.com/a-practical-approach-to-building-diversity-into-clinical-trials-using-purpose-built-sites/) - Achieving diversity in clinical trials is critical to ensuring safe, effective therapies and equitable health outcomes, as well as fostering trust in healthcare research. Increasingly, planning for diversity is also a key component of regulatory compliance, as agencies such as the US Food and Drug Administration (FDA) issue guidance on ensuring that studies reflect the
- [Successful Site Performance in a Phase 2b Influenza Prevention Study](https://allianceclinicalnetwork.com/successful-site-performance-in-a-phase-2b-influenza-prevention-study/) - Study ObjectivesEnroll 4,000 participants across multiple global sites.Alliance Clinical Network Goal: Enroll 300 participants (150 per site) within a challenging 8-week enrollment window.ChallengesDuring the execution of the study, Alliance Clinical Network faced several operational and logistical hurdles, including: Download the case study by submitting the form below Download the case study by submitting the form
- [History of GLP-1 Approvals in the U.S.](https://allianceclinicalnetwork.com/history-of-glp-1-approvals-in-the-u-s/) - The following table provides a brief history of GLP-1 therapies that have received FDA regulatory approval. In addition to identifying brand name, manufacturer and launch date, the chart shows whether the product received regulatory approval for weight loss or diabetes indications. Brand Name Generic Name Sponsor / Manufacturer Indication Launch Date Byetta exenatide AstraZeneca Diabetes 4/28/05 Victoza
- [Delivering on Diversity in a Phase 2b Diabetic Peripheral Neuropathy Study](https://allianceclinicalnetwork.com/delivering-on-diversity-in-a-phase-2b-diabetic-peripheral-neuropathy-study/) - Study ObjectivesEnrollment of 416 participants, across 100 sites, study wideAlliance Clinical Network Goal: Enroll 10 participantsChallengesDuring the execution of the study, Alliance Clinical Network encountered some challenges, including:Study Population Diversity: Identifying participants who not only meet the strict inclusion/ exclusion criteria but also help increase diversity across the study population.Screen Failure Rates: Screen fail rates
- [How eSource Empowers Clinical Sites to Perform at Their Best](https://allianceclinicalnetwork.com/how-esource-empowers-clinical-sites-to-perform-at-their-best/) - As clinical studies become more complex and timelines contract, clinical research sites face pressure to deliver high-quality data, remain compliant, and activate studies quickly. Legacy paper-based workflows, once standard, now pose real limitations, introducing errors, delaying timelines, and increasing risk. Electronic source (eSource) systems provide a solution. By digitizing data capture at the point of care,
- [Streamlining Recruitment in a Phase 3 Pulmonary Study](https://allianceclinicalnetwork.com/streamlining-recruitment-in-a-phase-3-pulmonary-study/) - Study ObjectivesCompetitive enrollment of 5,000 participants across multiple sites, within a 48-month enrollment window.Alliance Clinical Network Goal: Enroll 30 participants (10 per site).ChallengesDuring the execution of the study, Alliance Clinical Network encountered some operational and logistical hurdles, including:Spirometry Issues: Many sites had their own spirometry machines that were qualified by the Sponsor for use but
- [Site-Level Strategies to Drive Better Clinical Research Outcomes in Type 2 Diabetes Trials](https://allianceclinicalnetwork.com/site-level-strategies-to-drive-better-clinical-research-outcomes-in-type-2-diabetes-trials/) - Conducting clinical trials in Type 2 Diabetes (T2D) presents a unique set of challenges at the site level. Sites are responsible for managing participant recruitment, ensuring adherence, maintaining data integrity, and addressing socioeconomic barriers that impact study outcomes. While sponsors and regulatory bodies set study protocols, sites play a crucial role in overcoming operational hurdles
- [Accelerating Enrollment in a Phase 2b Atopic Dermatitis Study](https://allianceclinicalnetwork.com/accelerating-enrollment-in-a-phase-2b-atopic-dermatitis-study/) - Study ObjectivesEnrollment of 250 participants, across 100 sites, study wideAlliance Clinical Network Goal: Enroll 10 participants in 6 months ChallengesDuring the execution of the study, we encountered some challenges, including:Strict inclusion/ exclusion criteria: Identifying participants who met the specific criteria to enroll into one of the two study populations: Biologic-experienced patients vs. biologic-naïve. Download the case
- [Proven Site Strategies: Accelerating Startup, Recruitment, and Retention in Dermatology Clinical Trials](https://allianceclinicalnetwork.com/proven-site-strategies-accelerating-startup-recruitment-and-retention-in-dermatology-clinical-trials/) - Clinical trials are the engine of medical progress, yet in dermatology, their velocity is often hindered by operational friction. While innovative therapies for chronic and rare skin diseases advance through the pipeline, the time it takes to activate trial sites and enroll participants can mean the difference between first-to-market leadership and a stalled clinical program.This
- [Exceeding Enrollment Goals in a Phase 3 Severe Hypertriglyceridemia Study](https://allianceclinicalnetwork.com/exceeding-enrollment-goals-in-a-phase-3-severe-hypertriglyceridemia-study/) - Study ObjectivesStudy enrollment goal of 300 participants across 140 sites, across 17 countries.Alliance Clinical Network Goal: Enroll 1 participant/month.ChallengesDuring the execution of the study, Alliance Clinical Network encountered some challenges, including:Extensive eligibility criteria: Restrictive study eligibility criteria limit the number of participants who qualify for the study.Screen Failure Rates: Screen fail rates for CNS trials
- [Checklist to Optimize Recruitment and Retention in Cardiometabolic Clinical Trials](https://allianceclinicalnetwork.com/checklist-to-optimize-recruitment-and-retention-in-cardiometabolic-clinical-trials/) - This checklist is a practical tool for clinical development professionals at sponsor and CRO organizations. It reflects regulatory guidance (FDA, ICH E6(R3), EMA), evidence-based practices, and operational strategies to optimize recruitment and retention of patients in cardiometabolic clinical trials. such as diabetes, obesity, heart failure, chronic kidney disease, atherosclerotic cardiovascular disease. Governance and Recruitment Action
- [Ensuring Diversity in Clinical Trial Enrollment: A Mandate for Change](https://allianceclinicalnetwork.com/ensuring-diversity-in-clinical-trial-enrollment-a-mandate-for-change/) - 4 Minute Read Clinical trials—and the sites where these studies are conducted—exist to prove the safety and efficacy of therapies and other medical products. Yet, their results are only helpful if they accurately reflect outcomes in the entire target population. For too long, that has not been the case; historically, clinical trial participants have been
- [More than advertised: A new study spotted something that might be huge—the recombinant shingles vaccine is linked to reduced dementia risk, especially in women.](https://allianceclinicalnetwork.com/more-than-advertised-a-new-study-spotted-something-that-might-be-huge-the-recombinant-shingles-vaccine-is-linked-to-reduced-dementia-risk-especially-in-women/) - 3 Minute Read Read More
- [No needles required: The FDA approves an at-home flu vaccine](https://allianceclinicalnetwork.com/no-needles-required-the-fda-approves-an-at-home-flu-vaccine/)
- [Alliance Clinical Welcomes Pete Beardsley as Chief Commercial Officer](https://allianceclinicalnetwork.com/alliance-clinical-welcomes-pete-beardsley-as-chief-commercial-officer/) - Southlake, Texas, October 1, 2024: Today, Alliance Clinical Network announced that Pete Beardsley will join the company as Chief Commercial Officer. Mr. Beardsley will lead Alliance Clinical’s commercial functions, maximizing revenue generation, accelerating business development, and guiding the organization to the next stage of growth. Alliance Clinical Network Chief Executive Officer, Anthony Abey, explains, “We
- [Study: Black Americans' perceptions of Alzheimer's disease, a healthy brain and strategies for brain health promotion](https://allianceclinicalnetwork.com/study-black-americans-perceptions-of-alzheimers-disease-a-healthy-brain-and-strategies-for-brain-health-promotion/) - 3 Minute Read Read More
- [Prioritizing Diversity in Vaccine Clinical Trials: 5 Strategies for Success](https://allianceclinicalnetwork.com/prioritizing-diversity-in-vaccine-clinical-trials-5-strategies-for-success/) - 5 Minute Read Clinical trial diversity is essential to ensure novel therapeutics are effective and safe for the populations they are intended to treat. Vaccines are no exception, as they can differentially affect groups reflecting variation in environmental exposure and underlying experiences. However, diversity has historically been an issue in vaccine studies. An analysis of
- [Overcoming Challenges in Obesity Clinical Trials: A Patient-Centric Approach](https://allianceclinicalnetwork.com/overcoming-challenges-in-obesity-clinical-trials-a-patient-centric-approach/) - 5 Minute Read Obesity is a growing global health issue, with its prevalence reaching epidemic proportions. Affecting more than one billion people worldwide, obesity is a complex, multifactorial condition that requires multifaceted treatment strategies.1 As the need for effective obesity interventions increases, so does the importance of well-executed clinical trials with well-chosen clinical trial sites.
- [5 Keys to Maximizing Patient Recruitment and Retention in Dermatology Clinical Trials](https://allianceclinicalnetwork.com/5-keys-to-maximizing-patient-recruitment-and-retention-in-dermatology-clinical-trials/) - Skin conditions are among the most common health issues worldwide, increasing the demand for effective, long-lasting treatments. In the US, the dermatology drug market is projected to reach $9.11 billion in 2025 and is expected to grow at a compound annual growth rate (CAGR) of 9.7% to reach $14.48 billion by 2030.1 Yet, the landscape
- [Standardizing MASH Assessments with the FDA’s First AI-Qualified Histology Tool](https://allianceclinicalnetwork.com/standardizing-mash-assessments-with-the-fdas-first-ai-qualified-histology-tool/) - In December 2025, the U.S. Food and Drug Administration (FDA) qualified the first artificial intelligence (AI)–powered drug development tool for use in clinical trials for metabolic dysfunction-associated steatohepatitis (MASH).1 The AI-Based Histologic Measurement of NASH (AIM-NASH) tool was qualified under the FDA’s Drug Development Tool (DDT) program, marking a significant regulatory milestone for the use
- [A Proven Framework for Clinical Site Performance Trial Success](https://allianceclinicalnetwork.com/a-proven-framework-for-clinical-site-performance-trial-success/) - For sponsors and CROs, the gap between protocol design and trial execution often hinges on site performance. As clinical trials become more complex, enrollment targets become more challenging to achieve, and cost pressures intensify, traditional oversight models often fall short. What is needed is a proactive, metric-driven approach that strengthens site partnerships, reduces risk, and
- [Advancing GLP-1s Through Neuropsychiatry-Focused Clinical Research](https://allianceclinicalnetwork.com/advancing-glp-1s-through-neuropsychiatry-focused-clinical-research/) - A New Frontier at the Intersection of Metabolism and Mental Health Glucagon-like peptide-1 (GLP-1) receptor agonists have shifted from a metabolic innovation to a broader therapeutic phenomenon. Prescribing increased more than 300 percent between 2019 and 2022, driven by the U.S. obesity crisis and the growing adoption of semaglutide and related agents for weight management.1,2
- [Quality & Compliance: Foundations for Site Network Success](https://allianceclinicalnetwork.com/quality-compliance-foundations-for-site-network-success/) - Quality and compliance are not back-office functions in clinical research—they are the foundation upon which participant safety, scientific validity, and regulatory approval rest. In an increasingly complex research landscape, high-performing clinical research sites understand that quality is not inspected into a study at the end; it is deliberately designed into every process from feasibility to
- [Driving Operational Excellence Across Site Operations](https://allianceclinicalnetwork.com/driving-operational-excellence-across-site-operations/) - In an environment where clinical trials are growing more complex and timelines are under increasing pressure, operational excellence has become a defining differentiator for high-performing research networks. Sponsors have a right to expect predictable enrollment, high-quality data, and a positive patient experience. Yet, trial sites can’t simply work harder or faster. Achieving these outcomes requires a

## Pages

- [Home](https://allianceclinicalnetwork.com/) - Alliance Clinical Network is a purpose-built clinical research site network delivering rapid study startup, diverse participant enrollment, and audit-ready data for clinical trials.
- [News & Insights](https://allianceclinicalnetwork.com/news-and-insights/) - News & Insights FEATURED INSIGHT Case Study Rapid Enrollment of Phase 3 GLP-1 Obesity Study READ MORE Case Study July 17, 2026 | 5 minute read Surpassing Recruitment Goals in a Phase 3 Cardiovascular Disease Clinical Trial READ MORE Therapeutic Expertise Select... CNS Dermatology General Metabolics & Obesity Vaccines & Immunology Resource Type Select... Therapeutic
- [Feasibility Request](https://allianceclinicalnetwork.com/feasibility-request/) - Activate your Trial with a Feasibility Assessment At Alliance Clinical Network, we know that every day counts in the development of new treatments. Share your study with us and discover how we can accelerate every stage — from diverse patient recruitment to seamless protocol execution. Request Feasibility Assessment 500,000+​Prescreened Participants 85%Underrepresented Groups 500,000+​Prescreened Participants 85%Underrepresented
- [Flagship Locations](https://allianceclinicalnetwork.com/flagship-locations/) - Explore Alliance Clinical Network’s flagship clinical trial sites across key U.S. markets, supporting diverse research studies led by experienced investigators.
- [IBC Meeting Minutes](https://allianceclinicalnetwork.com/ibc-meeting-minutes/) - IBC Meeting Minutes Swipe left to view all table columns → IBC Meeting Minutes for Alliance Clinical Network locations Site/Institution Name Street Street 2 City State ZIP IBC Minute Website Alliance Clinical Dallas 7777 Forest Lane Suite C-855 Dallas TX 75230 View IBC Minutes Alliance Clinical Lewisville 500 West Main Street Suite 320 Lewisville TX
- [Las Vegas](https://allianceclinicalnetwork.com/flagship-locations/las-vegas/) - Alliance Clinical Network’s Las Vegas flagship clinical trial site (formerly Excel Clinical Research) supports a broad range of clinical studies led by experienced investigators and research teams.
- [San Diego](https://allianceclinicalnetwork.com/flagship-locations/san-diego/) - Alliance Clinical Network’s San Diego flagship clinical trial site (formerly Acclaim Clinical Research) supports a broad range of clinical studies led by experienced investigators and research teams.
- [Los Angeles](https://allianceclinicalnetwork.com/flagship-locations/los-angeles/) - Alliance Clinical Network’s Los Angeles flagship clinical trial site (formerly 310 Clinical Research) supports a broad range of clinical studies led by experienced investigators and research teams.
- [Phoenix](https://allianceclinicalnetwork.com/flagship-locations/phoenix/) - Alliance Clinical Network’s Phoenix flagship clinical trial site supports a broad range of clinical studies led by experienced investigators and research teams.
- [West Hills](https://allianceclinicalnetwork.com/flagship-locations/west-hills/) - Alliance Clinical Network’s West Hills flagship clinical trial site (formerly Focus Clinical Research) supports a broad range of clinical studies led by experienced investigators and research teams.
- [Lewisville](https://allianceclinicalnetwork.com/flagship-locations/lewisville/) - Alliance Clinical Network’s Lewisville flagship clinical trial site (formerly Epic Clinical Research) supports a broad range of clinical studies led by experienced investigators and research teams.
- [Canoga Park](https://allianceclinicalnetwork.com/flagship-locations/canoga-park/) - Alliance Clinical Network’s Canoga Park flagship clinical trial site (formerly Hope Clinical Research) supports a broad range of clinical studies led by experienced investigators and research teams.
- [Careers](https://allianceclinicalnetwork.com/careers/) - Careers Join Our Community Every day, we bring our energy and our passion to improving patients’ lives. From answering our participants’ questions to running their lab tests, our work helps advance medical science and bring new therapies to life. Are you one of us? “It’s a place where people love coming to work—and stay because
- [Terms of Use](https://allianceclinicalnetwork.com/terms-of-use/) - Terms of Use Effective as of June 10, 2024AGREEMENT TO OUR LEGAL TERMSWe are Alliance Clinical Network (“Company,” “we,” “us,” “our”), a company registered in Texas, United States at 601 State Street, Suite 280, Southlake, TX 76092.We operate the website http://www.allianceclinicalnetwork.com (the “Site”), as well as any other related products and services that refer or
- [Recruitment & Diversity](https://allianceclinicalnetwork.com/recruitment-diversity/) - Alliance Clinical Network’s clinical trial sites deliver efficient recruitment supported by a diverse, pre-screened participant population.
- [Capabilities](https://allianceclinicalnetwork.com/capabilities/) - Alliance Clinical Network’s clinical trial sites deliver standardized capabilities ensuring consistent, high-quality execution across research programs.
- [Audit-Ready Data](https://allianceclinicalnetwork.com/audit-ready-data/) - Alliance Clinical Network’s clinical trial sites deliver audit-ready data supported by standardized processes and centralized quality oversight.
- [What Defines Us](https://allianceclinicalnetwork.com/what-defines-us/) - What Defines Us Mission Statement At Alliance Clinical, our mission is to advance medical research by enrolling diverse populations in high-quality clinical trials. We are committed to maintaining the highest standards of integrity and excellence, and to ensuring that every participant receives respectful and compassionate care. We strive to build a tightly knit, supportive and
- [Who We Are](https://allianceclinicalnetwork.com/who-we-are/) - Meet the experienced leadership, hands-on management team, and dedicated medical staff behind Alliance Clinical Network advancing clinical research with quality and purpose.
- [Dallas](https://allianceclinicalnetwork.com/flagship-locations/dallas/) - Alliance Clinical Network’s Dallas flagship clinical trial site (formerly Zenos Clinical Research) supports a broad range of clinical studies led by experienced investigators and research teams.
- [Privacy Policy](https://allianceclinicalnetwork.com/privacy-policy/) - Privacy Policy Last Updated: 10Feb2026 Alliance Clinical Network (“we,” “our,” “us”) is committed to protecting your privacy. This Privacy Policy explains how we collect, use, share, and protect personal information when you visit our website, use our services, or interact with us in any way. This Privacy Policy is designed to comply with the General
- [Dermatology](https://allianceclinicalnetwork.com/therapeutic-expertise/dermatology/) - Alliance Clinical Network’s dermatology clinical trial sites support a broad range of skin-related indications with experienced investigators and research teams.
- [Metabolics & Obesity](https://allianceclinicalnetwork.com/therapeutic-expertise/metabolics-and-obesity/) - Alliance Clinical Network’s metabolics and obesity clinical trial sites support studies across metabolic disorders and obesity-related indications.
- [CNS](https://allianceclinicalnetwork.com/therapeutic-expertise/cns/) - Alliance Clinical Network’s CNS clinical trial sites support neurological and central nervous system studies led by experienced investigators.
- [Vaccines & Immunology](https://allianceclinicalnetwork.com/therapeutic-expertise/vaccines-immunology/) - Alliance Clinical Network’s vaccines and immunology clinical trial sites support vaccine and immune-related studies led by experienced investigators.
- [Therapeutic Expertise](https://allianceclinicalnetwork.com/therapeutic-expertise/) - Alliance Clinical Network’s clinical trial sites provide therapeutic expertise across multiple indications, supporting diverse clinical research studies.
- [Do Not Sell or Share My Personal Information](https://allianceclinicalnetwork.com/do-not-sell/) - Do Not Sell or Share My Personal Information Under applicable U.S. privacy laws, you have the right to opt out of the use of your information for targeted advertising and the sale or sharing of your personal information. To submit an opt-out request, please complete the form. Do Not Sell or Share My Personal Information
- [Thank You – Guide Download Form](https://allianceclinicalnetwork.com/guide-download-thank-you/) - Thanks — Your Guide Is On Its Way We’ve emailed the guide to you as a PDF. Please check your inbox (and spam folder, just in case). Go Back to Website Thank You! Your download has started automatically. Please check your browser's "Downloads" folder to access the file. We hope this resource is valuable to
- [Thank You - Case Study Download Forms](https://allianceclinicalnetwork.com/case-study-download-thank-you/) - Thanks — Your Case Study Is On Its Way We’ve emailed the case study to you as a PDF. Please check your inbox (and spam folder, just in case). Go Back to Website Thank You! Your download has started automatically. Please check your browser's "Downloads" folder to access the file. We hope this resource is
- [Thank You - Feasibility Form](https://allianceclinicalnetwork.com/feasibility-request-thank-you/) - Thank you for your submission! We will be in touch shortly. If you don’t hear from us, please check your junk or spam folder. Go Back to Website
- [Thank You - Contact Us Forms](https://allianceclinicalnetwork.com/contact-thank-you/) - Thank you for your submission! We will be in touch shortly. If you don’t hear from us, please check your junk or spam folder. Go Back to Website
- [Test Facet](https://allianceclinicalnetwork.com/test-facet/)
- [Test News & Insights](https://allianceclinicalnetwork.com/test-news-insights/)
- [Opt-out preferences](https://allianceclinicalnetwork.com/opt-out-preferences/) - [cmplz-document type="cookie-statement" region="us"]

## Categories

- [Alliance Clinical Insights](https://allianceclinicalnetwork.com/category/alliance-clinical-insights/)
- [Alliance Clinical News](https://allianceclinicalnetwork.com/category/alliance-clinical-news/)
- [Trending News](https://allianceclinicalnetwork.com/category/trending-news/)
- [Guide](https://allianceclinicalnetwork.com/category/guide/)
- [Case Study](https://allianceclinicalnetwork.com/category/case-study/)
- [Industry Resources](https://allianceclinicalnetwork.com/category/industry-resources/)
- [Featured Insight](https://allianceclinicalnetwork.com/category/featured-insight/)

## Tags

- [Metabolics & Obesity](https://allianceclinicalnetwork.com/tag/metabolics-obesity/)
- [Dermatology](https://allianceclinicalnetwork.com/tag/dermatology/)
- [CNS](https://allianceclinicalnetwork.com/tag/cns/)
- [General](https://allianceclinicalnetwork.com/tag/general/)
- [Vaccines & Immunology](https://allianceclinicalnetwork.com/tag/vaccines-immunology/)